EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer

Kunqiao Hong, Qian Yang, Haisen Yin, Jianwei Zhang, Baoping Yu

Open Life Sciences · 20.06.2023 · 18 (1)

DOI: 10.1515/biol-2022-0630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Life Sciences, online erschienen am 20.06.2023. Verfasst von Kunqiao Hong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital of Wuhan University, Wuhan, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PAAD) is usually found when it is already in its advanced stage, which has limited options available for treatment and poor overall survival. The SDR16C5 gene is necessary for embryonic and adult tissue differentiation, development, and apoptosis, and it also participates in immune response and regulates energy metabolism. However, the role of SDR16C5 in PAAD remains unclear. In this study, we find that SDR16C5 was highly expressed in multiple tumors including PAAD. Furthermore, higher expression of SDR16C5 was significantly associated with poorer survival. We also find that the knockdown of SDR16C5 can inhibit PAAD cell proliferation and promote cell apoptosis by repressing Bcl-2, cleaved caspase 3, and cleaved caspase 9 protein expression. Moreover, silencing SDR16C5 inhibits the migration of PANC-1 and SW1990 cells by interrupting epithelial–mesenchymal transition. KEGG pathway analysis and immunofluorescence staining indicate that SDR16C5 is associated with immunity and may also participate in the development of PAAD through the IL-17 signaling pathway. Collectively, our findings provide evidence that SDR16C5 is overexpressed in PAAD patients and promotes its proliferation, migration, invasion, and apoptosis-inhibition of PAAD cells. Thus, SDR16C5 may be a potential prognostic and therapeutic target.

Schlagwörter

Stichwörter der Autor:innen

SDR16C5apoptosismigrationpancreatic cancerproliferation

Autor:innen und Institutionen

  • Department of Gastroenterology, Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Gastroenterology, Guizhou Provincial People's Hospital, Guiyang City, Guizhou Province, China.
  • NHC Key Laboratory of Pulmonary Immune-related Disease, Guizhou Provincial People's Hospital, Guiyang City, Guizhou Province, China.

Zitieren

APA

Hong, K., Yang, Q., Yin, H., Zhang, J., & Yu, B. (2023). SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer. Open Life Sciences, 18(1). https://doi.org/10.1515/biol-2022-0630

Vancouver

Hong K, Yang Q, Yin H, Zhang J, Yu B. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer. Open Life Sciences. 2023;18(1). doi:10.1515/biol-2022-0630

BibTeX
@article{Hong2023,
  author = {Hong, Kunqiao and Yang, Qian and Yin, Haisen and Zhang, Jianwei and Yu, Baoping},
  title = {SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer},
  journal = {Open Life Sciences},
  year = {2023},
  volume = {18},
  number = {1},
  doi = {10.1515/biol-2022-0630}
}
Kostenlos starten →